David co-founded Bactolife™ in August 2017.

David Kauffmann is founder and partner on European Equity Partners (EEP). He was Chairman of CMC Biologics (now AGC Biologics) prior to its successful sale to AGC Japan, and Chairman of the Management Board of Aster Cephac SA. Both at AGC Biologics and at Aster Cephac, he was instrumental in building these two companies over 16 and 10 years, respectively, to international leaders in their industries.

He is currently Chairman of Azanta A/S and a Board Director of AGC Biologics Inc.